These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 4468110
1. Effects of some antiparkinsonism drugs and centrally acting muscle relaxants on the intercollicular decerebrate rigidity in rats. Fukuda H, Ito T, Kokubo M. Chem Pharm Bull (Tokyo); 1974 Dec; 22(12):2883-8. PubMed ID: 4468110 [No Abstract] [Full Text] [Related]
2. Quantification of the effects of muscle relaxant drugs in man by tonic stretch reflex. Meyer M, Adorjáni C. Adv Neurol; 1983 Dec; 39():997-1011. PubMed ID: 6660131 [No Abstract] [Full Text] [Related]
3. Pharmacological properties of NK433, a new centrally acting muscle relaxant. Sakitama K, Ozawa Y, Aoto N, Nakamura K, Ishikawa M. Eur J Pharmacol; 1995 Jan 24; 273(1-2):47-56. PubMed ID: 7737318 [Abstract] [Full Text] [Related]
4. Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats. Matsunaga M, Uemura Y, Yonemoto Y, Kanai K, Etoh H, Tanaka S, Atsuta Y, Nishizawa Y, Yamanishi Y. Jpn J Pharmacol; 1997 Mar 24; 73(3):215-20. PubMed ID: 9127816 [Abstract] [Full Text] [Related]
5. The pharmacology of fletazepam a centrally-acting muscle relaxant. Barnett A, Goldstein J, Fiedler EP, Taber RI. Arch Int Pharmacodyn Ther; 1974 Nov 24; 212(1):164-74. PubMed ID: 4476200 [No Abstract] [Full Text] [Related]
7. Pharmacology of M & B 18,706, a drug which selectively reduces decerebrate rigidity. Maxwell DR, Read MA, Sumpter EA. Br J Pharmacol; 1974 Jan 24; 50(1):35-45. PubMed ID: 4150889 [Abstract] [Full Text] [Related]
8. Reduction in excessive muscle tone by selective depletion of serotonin in intercollicularly decerebrated rats. Sakai M, Matsunaga M, Kubota A, Yamanishi Y, Nishizawa Y. Brain Res; 2000 Mar 31; 860(1-2):104-11. PubMed ID: 10727628 [Abstract] [Full Text] [Related]
9. Pharmacological properties of the new centrally acting muscle relaxant (R)-(+)-3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl]isoxazole hydrochloride. Otsu T, Kawabata H, Horikomi K, Tanada H, Sakai K, Matsubara A, Mizuchi A. Arzneimittelforschung; 1997 Jun 31; 47(6):706-9. PubMed ID: 9239447 [Abstract] [Full Text] [Related]
10. Cyclobenzaprine: a possible mechanism of action for its muscle relaxant effect. Commissiong JW, Karoum F, Reiffenstein RJ, Neff NH. Can J Physiol Pharmacol; 1981 Jan 31; 59(1):37-44. PubMed ID: 7214207 [Abstract] [Full Text] [Related]
11. A new class of potent centrally acting muscle relaxants: pharmacology of oxazolidinones in rat decerebrate rigidity. Masaki M, Shinozaki H. Br J Pharmacol; 1986 Sep 31; 89(1):219-28. PubMed ID: 2879590 [Abstract] [Full Text] [Related]
12. Local cerebral glucose utilization in rats with decerebrate rigidity and effects of centrally acting muscle relaxants, diazepam and tizanidine. Nakamura T, Ono H, Fukuda H, Tanabe M, Kozuka M, Iwata N. Biol Pharm Bull; 1993 Jan 31; 16(1):33-5. PubMed ID: 8369748 [Abstract] [Full Text] [Related]
13. Pharmacological studies of 1-(2,3-dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1- propanone hydrochloride (AD-2239), a centrally acting muscle relaxant. Ito T, Hori M, Furukawa K, Karasawa T, Kadokawa T. Arch Int Pharmacodyn Ther; 1985 May 31; 275(1):105-22. PubMed ID: 3839647 [Abstract] [Full Text] [Related]
14. Muscle rigidity induced by fluphenazine in rats is antagonized by L-DOPA, an antiparkinsonian drug. Ossowska K, Konieczny J, Lorenc-Koci E, Schulze G, Coper H, Wolfarth S. J Physiol Pharmacol; 1998 Jun 31; 49(2):311-7. PubMed ID: 9670114 [Abstract] [Full Text] [Related]
15. A comparison of the actions of some drugs on decerebrate rigidity, muscle spindle activity and alpha-adrenoceptors. Maxwell DR, Sumpter EA. Br J Pharmacol; 1974 Mar 31; 50(3):355-63. PubMed ID: 4277330 [Abstract] [Full Text] [Related]